Human medicines European public assessment report (EPAR): Padcev, enfortumab vedotin, Date of authorisation: 13/04/2022, Revision: 11, Status: Authorised
الصحة واللياقة البدنية
Human medicines European public assessment report (EPAR): Padcev, enfortumab vedotin, Date of authorisation: 13/04/2022, Revision: 11, Status: Authorised
Human medicines European public assessment report (EPAR): Padcev, enfortumab vedotin, Date of authorisation: 13/04/2022, Revision: 11, Status: Authorised
AAdmin
١٦ أكتوبر ٢٠٢٦
1 دقيقة قراءة
